康寧醫院(02120.HK)擬1.55億元收購平陽長庚怡寧醫院100%股權
格隆匯8月20日丨康寧醫院(02120.HK)宣佈,於2021年8月20日,公司與目標公司平陽長庚怡寧醫院以及現有股東訂立投資協議。據此,公司已有條件同意通過增資及股權轉讓相結合的方式取得目標公司100%的股權。投資事項的總代價為人民幣1.55億元。於投資事項完成後,目標公司將會成為公司的全資附屬公司。
據悉,目標公司為於中國註冊成立的有限責任公司,主要從事醫療服務、醫院管理、護理機構服務以及養老服務等業務。目標公司曾持有平陽長庚醫院100%股權。於2021年7月,目標公司吸收合併平陽長庚醫院,繼受其全部債權債務及業務資質,平陽長庚醫院予以註銷。目標公司現實際營運一家名為平陽長庚怡寧醫院的醫療機構。平陽長庚怡寧醫院是一所集醫療、預防保健、康復為一體的綜合性醫院,自有土地面積13,333平方米,自有物業建築面積約22,100平方米,運營牀位數450張,年門診量約16萬人次。截至公吿期,目標公司擁有約230名全職僱員,其中醫務人員約180名。
通過此次投資事項,公司將進一步加強在老年康復醫療領域的佈局,整合在浙江南部地區醫療資源,提升整體運營效率。一是隨着中國人口老齡化進程,温州地區的老年康復醫療需求增加,公司於2016年設立的温州怡寧老年醫院牀位接近飽和,收購目標公司可以緩解温州怡寧老年醫院的牀位壓力;二是公司於平陽縣設立了精神專科醫院平陽康寧醫院,收購目標公司可以與平陽康寧醫院在業務上協同和互補,提升兩家醫療機構的醫療資源利用效率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.